Literature DB >> 25104085

Molecular pathways: regulation and targeting of kinetochore-microtubule attachment in cancer.

Jacob A Herman1, Chad M Toledo2, James M Olson3, Jennifer G DeLuca4, Patrick J Paddison5.   

Abstract

Kinetochores are large protein structures assembled on centromeric DNA during mitosis that bind to microtubules of the mitotic spindle to orchestrate and power chromosome movements. Deregulation of kinetochore-microtubule (KT-MT) attachments has been implicated in driving chromosome instability and cancer evolution; however, the nature and source of KT-MT attachment defects in cancer cells remain largely unknown. Here, we highlight recent findings suggesting that oncogene-driven changes in kinetochore regulation occur in glioblastoma multiforme (GBM) and possibly other cancers exhibiting chromosome instability, giving rise to novel therapeutic opportunities. In particular, we consider the GLE2p-binding sequence domains of BubR1 and the newly discovered BuGZ, two kinetochore-associated proteins, as candidate therapeutic targets for GBM. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25104085      PMCID: PMC4297562          DOI: 10.1158/1078-0432.CCR-13-0645

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  66 in total

1.  The mitotic checkpoint protein hBUB3 and the mRNA export factor hRAE1 interact with GLE2p-binding sequence (GLEBS)-containing proteins.

Authors:  X Wang; J R Babu; J M Harden; S A Jablonski; M H Gazi; W L Lingle; P C de Groen; T J Yen; J M van Deursen
Journal:  J Biol Chem       Date:  2001-05-14       Impact factor: 5.157

2.  Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.

Authors:  J Chen; J Xie; Z Jiang; B Wang; Y Wang; X Hu
Journal:  Oncogene       Date:  2011-04-25       Impact factor: 9.867

3.  Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism.

Authors:  Sandeep K Talapatra; Nahoum G Anthony; Simon P Mackay; Frank Kozielski
Journal:  J Med Chem       Date:  2013-08-22       Impact factor: 7.446

4.  Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.

Authors:  Bibo Yuan; Yi Xu; Ju-Hyung Woo; Yunyue Wang; Young Kyung Bae; Dae-Sung Yoon; Robert P Wersto; Ellen Tully; Kathleen Wilsbach; Edward Gabrielson
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

5.  Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations.

Authors:  ChongFeng Gao; Kyle Furge; Julie Koeman; Karl Dykema; Yanli Su; Mary Lou Cutler; Adam Werts; Pete Haak; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

Review 6.  Aurora kinase inhibitors in preclinical and clinical testing.

Authors:  Chun Hei Antonio Cheung; Mohane Selvaraj Coumar; Hsing-Pang Hsieh; Jang-Yang Chang
Journal:  Expert Opin Investig Drugs       Date:  2009-04       Impact factor: 6.206

7.  Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.

Authors:  Bakhos A Tannous; Mariam Kerami; Petra M Van der Stoop; Nicholas Kwiatkowski; Jinhua Wang; Wenjun Zhou; Almuth F Kessler; Grant Lewandrowski; Lotte Hiddingh; Nik Sol; Tonny Lagerweij; Laurine Wedekind; Johanna M Niers; Marco Barazas; R Jonas A Nilsson; Dirk Geerts; Philip C De Witt Hamer; Carsten Hagemann; W Peter Vandertop; Olaf Van Tellingen; David P Noske; Nathanael S Gray; Thomas Würdinger
Journal:  J Natl Cancer Inst       Date:  2013-08-12       Impact factor: 13.506

Review 8.  The spindle-assembly checkpoint in space and time.

Authors:  Andrea Musacchio; Edward D Salmon
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04-11       Impact factor: 94.444

Review 9.  The spindle assembly checkpoint.

Authors:  Pablo Lara-Gonzalez; Frederick G Westhorpe; Stephen S Taylor
Journal:  Curr Biol       Date:  2012-11-20       Impact factor: 10.834

10.  The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression.

Authors:  Li Bie; Gang Zhao; Pui Cheng; Gaelle Rondeau; Steffen Porwollik; Yan Ju; Xiao-Qin Xia; Michael McClelland
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

View more
  11 in total

1.  CNS Anticancer Drug Discovery and Development Conference White Paper.

Authors:  Victor A Levin; Peter J Tonge; James M Gallo; Marc R Birtwistle; Arvin C Dar; Antonio Iavarone; Patrick J Paddison; Timothy P Heffron; William F Elmquist; Jean E Lachowicz; Ted W Johnson; Forest M White; Joohee Sul; Quentin R Smith; Wang Shen; Jann N Sarkaria; Ramakrishna Samala; Patrick Y Wen; Donald A Berry; Russell C Petter
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

Review 2.  Targeting mitotic pathways for endocrine-related cancer therapeutics.

Authors:  Shivangi Agarwal; Dileep Varma
Journal:  Endocr Relat Cancer       Date:  2017-06-14       Impact factor: 5.678

3.  Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells.

Authors:  Philippe Diaz; Eric Horne; Cong Xu; Ernest Hamel; Michael Wagenbach; Ravil R Petrov; Benjamin Uhlenbruck; Brian Haas; Parvinder Hothi; Linda Wordeman; Rick Gussio; Nephi Stella
Journal:  Eur J Med Chem       Date:  2018-09-11       Impact factor: 6.514

4.  Sensitivity to BUB1B Inhibition Defines an Alternative Classification of Glioblastoma.

Authors:  Eunjee Lee; Margaret Pain; Huaien Wang; Jacob A Herman; Chad M Toledo; Jennifer G DeLuca; Raymund L Yong; Patrick Paddison; Jun Zhu
Journal:  Cancer Res       Date:  2017-08-30       Impact factor: 12.701

5.  ZNF131 suppresses centrosome fragmentation in glioblastoma stem-like cells through regulation of HAUS5.

Authors:  Yu Ding; Jacob A Herman; Chad M Toledo; Jackie M Lang; Philip Corrin; Emily J Girard; Ryan Basom; Jeffrey J Delrow; James M Olson; Patrick J Paddison
Journal:  Oncotarget       Date:  2017-07-25

6.  Screening and authentication of molecular markers in malignant glioblastoma based on gene expression profiles.

Authors:  Yang-Fan Zou; Ling-Bing Meng; Zhao-Kai He; Chen-Hao Hu; Meng-Jie Shan; Deng-Yuan Wang; Xin Yu
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

7.  A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis.

Authors:  Eric A Horne; Philippe Diaz; Patrick J Cimino; Erik Jung; Cong Xu; Ernest Hamel; Michael Wagenbach; Debra Kumasaka; Nicholas B Wageling; Daniel D Azorín; Frank Winkler; Linda G Wordeman; Eric C Holland; Nephi Stella
Journal:  Neurooncol Adv       Date:  2020-12-03

8.  A role for the mitotic proteins Bub3 and BuGZ in transcriptional regulation of catalase-3 expression.

Authors:  Yike Zhou; Shuangjie Shen; Chengcheng Du; Ying Wang; Yi Liu; Qun He
Journal:  PLoS Genet       Date:  2022-06-06       Impact factor: 6.020

9.  Mitosis-specific phosphorylation of Mis18α by Aurora B kinase enhances kinetochore recruitment of polo-like kinase 1.

Authors:  Minkyoung Lee; Ik Soo Kim; Koog Chan Park; Jong-Seo Kim; Sung Hee Baek; Keun Il Kim
Journal:  Oncotarget       Date:  2017-11-27

10.  Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.

Authors:  Sandhya Yadav; Somnath D Bhagat; Amit Gupta; Atul Samaiya; Aasheesh Srivastava; Sanjeev Shukla
Journal:  BMC Cancer       Date:  2019-11-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.